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Through this research, they hoped to unlock the mystery behind pancreatic 
cancer, and design new therapies against these genes. 
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• ~40 different genes were mutated in more 
than 1 cancer 
• No two tumors are alike 
• The most common mutated genes were 
• KRAS 
• SMAD4 
• P16 
• P53 
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1) Which  mutations are most important? 
2) When is each mutation important? 
3) Why does each one occur? 
What do we do with this information? 
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 There are two top treatment regimens for advanced 
 pancreatic cancer: 
 A. Gemcitabine & Abraxane 
 B.  FOLFIRNOX  
Goal: to determine the mutations that directly 
cause resistance to these treatments in patients 
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1) Sequence and compare 
2) Identify unique mutations in resistant tumors 
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Innovative trial in patients that will  
 
1) Identify mutations that directly cause 
chemoresistance.  
 
2) Lead to new therapies to enhance treatment 
efficacy. 
 
3) This research is applicable to all cancers. 
Thanks for your attention! 
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